BR0108792A - Composto de polipeptìdeo, processo para sua preparação, composição farmacêutica contendo o mesmo, seu uso, método, embalagem comercial e artigo de manufatura - Google Patents

Composto de polipeptìdeo, processo para sua preparação, composição farmacêutica contendo o mesmo, seu uso, método, embalagem comercial e artigo de manufatura

Info

Publication number
BR0108792A
BR0108792A BR0108792-4A BR0108792A BR0108792A BR 0108792 A BR0108792 A BR 0108792A BR 0108792 A BR0108792 A BR 0108792A BR 0108792 A BR0108792 A BR 0108792A
Authority
BR
Brazil
Prior art keywords
preparation
pharmaceutical composition
polypeptide compound
composition containing
article
Prior art date
Application number
BR0108792-4A
Other languages
English (en)
Inventor
Ayako Toda
Takahiro Matsuya
Hiroaki Mizuno
Hiroshi Matsuda
Kenji Murano
David Barrett
Takashi Ogino
Keiji Matsuda
Original Assignee
Fujisawa Pharmaceutical Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from AUPQ5752A external-priority patent/AUPQ575200A0/en
Priority claimed from AUPQ9552A external-priority patent/AUPQ955200A0/en
Priority claimed from AUPR2344A external-priority patent/AUPR234400A0/en
Application filed by Fujisawa Pharmaceutical Co filed Critical Fujisawa Pharmaceutical Co
Publication of BR0108792A publication Critical patent/BR0108792A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/50—Cyclic peptides containing at least one abnormal peptide link
    • C07K7/54—Cyclic peptides containing at least one abnormal peptide link with at least one abnormal peptide link in the ring
    • C07K7/56—Cyclic peptides containing at least one abnormal peptide link with at least one abnormal peptide link in the ring the cyclisation not occurring through 2,4-diamino-butanoic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Biochemistry (AREA)
  • Oncology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Communicable Diseases (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)

Abstract

"COMPOSTO DE POLIPEPTìDEO, PROCESSO PARA SUA PREPARAçãO, COMPOSIçãO FARMACêUTICA CONTENDO O MESMO, SEU USO, MéTODO, EMBALAGEM COMERCIAL E ARTIGO DE MANUFATURA", a presente invenção refere-se a um novo composto de polipeptídeo representado pela seguinte fórmula geral(I): onde R^ 1^, R^ 2^, R^ 3^, R^ 5^ e R^ 6^ são conforme definido na descrição ou um sal do mesmo que possui atividades antimicrobianas (especial rnente atividades antifúngicas) , atividade inibidora sobre a sintase de <225>-1,3-glucano, a um processo para sua preparação, a uma composição farmacêutica compreendendo o mesmo, e a um método para tratamento profilático e/ou terapêutico de doenças infecciosas, incluindo infecção causada por Pneumocystis carinii (ex: pneumonia causada por Pneumocystis carinii) num ser humano ou animal.
BR0108792-4A 2000-02-21 2001-02-20 Composto de polipeptìdeo, processo para sua preparação, composição farmacêutica contendo o mesmo, seu uso, método, embalagem comercial e artigo de manufatura BR0108792A (pt)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
AUPQ5752A AUPQ575200A0 (en) 2000-02-21 2000-02-21 New compound
AUPQ9552A AUPQ955200A0 (en) 2000-08-21 2000-08-21 New compound
AUPR2344A AUPR234400A0 (en) 2000-12-28 2000-12-28 New compound
PCT/JP2001/001204 WO2001060846A1 (en) 2000-02-21 2001-02-20 Cyclic hexapeptide derivatives

Publications (1)

Publication Number Publication Date
BR0108792A true BR0108792A (pt) 2002-12-03

Family

ID=27158210

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0108792-4A BR0108792A (pt) 2000-02-21 2001-02-20 Composto de polipeptìdeo, processo para sua preparação, composição farmacêutica contendo o mesmo, seu uso, método, embalagem comercial e artigo de manufatura

Country Status (23)

Country Link
US (1) US6884774B2 (pt)
EP (1) EP1259535B1 (pt)
JP (1) JP3906690B2 (pt)
KR (1) KR100437176B1 (pt)
CN (1) CN1425026A (pt)
AR (1) AR033666A1 (pt)
AT (1) ATE293126T1 (pt)
BR (1) BR0108792A (pt)
CA (1) CA2400872C (pt)
CZ (1) CZ20022844A3 (pt)
DE (1) DE60110046T2 (pt)
ES (1) ES2236177T3 (pt)
HU (1) HUP0300066A3 (pt)
IL (1) IL150904A0 (pt)
MX (1) MXPA02008171A (pt)
NO (1) NO20023697L (pt)
NZ (1) NZ520808A (pt)
OA (1) OA12180A (pt)
PL (1) PL357875A1 (pt)
PT (1) PT1259535E (pt)
RU (1) RU2224765C1 (pt)
TW (1) TWI250992B (pt)
WO (1) WO2001060846A1 (pt)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AUPR362001A0 (en) * 2001-03-08 2001-04-05 Fujisawa Pharmaceutical Co., Ltd. New compound
DE60220415T2 (de) * 2001-07-27 2008-02-14 Neptune Technologies & Bioressources Inc., Laval Flavonoide und mehrfach ungesättigte fettsäuren enthaltende natürliche phospholipide maritimen ursprungs sowie deren anwendungen
AUPS044102A0 (en) * 2002-02-11 2002-03-07 Fujisawa Pharmaceutical Co., Ltd. New compound
AU2003903205A0 (en) * 2003-06-23 2003-07-10 Fujisawa Pharmaceutical Co., Ltd. New compound
AU2003903629A0 (en) * 2003-07-14 2003-07-31 Fujisawa Pharmaceutical Co., Ltd. New compound
US20100256048A1 (en) * 2007-10-29 2010-10-07 Astellas Pharma Inc. Polypeptide compound
CN107098884A (zh) 2016-02-19 2017-08-29 中国科学院上海药物研究所 一类取代的氨基吡啶类化合物及其制备和用途
JP2021510152A (ja) * 2018-01-04 2021-04-15 北京大学深▲ヂェン▼研究生院Ｐｅｋｉｎｇ Ｕｎｉｖｅｒｓｉｔｙ Ｓｈｅｎｚｈｅｎ Ｇｒａｄｕａｔｅ Ｓｃｈｏｏｌ Ｌｓｄ１とｈｄａｃとを標的として同時に阻害する化合物及びその用途

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5939384A (en) * 1991-10-01 1999-08-17 Merck & Co., Inc. Cyclohexapeptidyl propanolamine compounds
US6268338B1 (en) * 1993-04-30 2001-07-31 Merck & Co., Inc. Cyclohexapeptidyl amine compounds
US6107458A (en) * 1994-10-07 2000-08-22 Fujisawa Pharmaceutical Co., Ltd. Cyclic hexapeptides having antibiotic activity
JP3561917B2 (ja) * 1998-02-09 2004-09-08 藤沢薬品工業株式会社 新規化合物

Also Published As

Publication number Publication date
CZ20022844A3 (cs) 2003-01-15
CN1425026A (zh) 2003-06-18
NO20023697D0 (no) 2002-08-06
TWI250992B (en) 2006-03-11
US6884774B2 (en) 2005-04-26
IL150904A0 (en) 2003-02-12
RU2224765C1 (ru) 2004-02-27
US20030083238A1 (en) 2003-05-01
JP3906690B2 (ja) 2007-04-18
EP1259535A1 (en) 2002-11-27
AR033666A1 (es) 2004-01-07
MXPA02008171A (es) 2002-11-29
OA12180A (en) 2006-05-09
DE60110046T2 (de) 2005-11-17
CA2400872A1 (en) 2001-08-23
ATE293126T1 (de) 2005-04-15
DE60110046D1 (de) 2005-05-19
CA2400872C (en) 2010-11-16
EP1259535B1 (en) 2005-04-13
KR100437176B1 (ko) 2004-06-25
KR20020029792A (ko) 2002-04-19
RU2002125463A (ru) 2004-02-20
JP2003523349A (ja) 2003-08-05
HUP0300066A2 (hu) 2003-06-28
NZ520808A (en) 2004-03-26
NO20023697L (no) 2002-10-14
PT1259535E (pt) 2005-06-30
WO2001060846A1 (en) 2001-08-23
PL357875A1 (en) 2004-07-26
ES2236177T3 (es) 2005-07-16
HUP0300066A3 (en) 2004-07-28

Similar Documents

Publication Publication Date Title
BR9907967A (pt) Composto de polipeptideo, processo para sua preparação, composição farmacêutica compreendendo dito composto, e seu uso.
ES2234206T3 (es) Composicion antimocrobiana.
BRPI0415613A (pt) novos compostos de diazaspiroalcanos e seu uso no tratamento de doenças mediadas por ccr8
BRPI9504791B8 (pt) composto de polipeptídeo e composição farmacêutica.
BR0113822A (pt) Vacina
BRPI0412527A (pt) composto, uso do mesmo, composição farmacêutica, formulação farmacêutica em aerossol, método para o tratamento de um paciente humano ou animal com uma condição anti-inflamatória e/ou alérgica, e, processo para preparar um composto.
BR0210838A (pt) Composto, formulação farmacêutica, uso de um composto, métodos de prevenção e/ou tratamento de condições associadas com glicogênio sintase quinase-3, e de doenças, e medicação contraceptiva, e, processos para a preparação de um composto
GT200000123A (es) Formulacion de sal comun y moxifloxacina.
BR0012590A (pt) Composto, processo para a preparação do mesmo, formulação farmacêutica, uso de um composto, e, métodos para tratamento ou profilaxia de dor ou desconforto, e para tratamento ou profilaxia de dor neuropática ou central
EA201100312A1 (ru) Антимикробные агенты
CA2545157A1 (en) Disinfecting composition and methods of making and using same
BR0214243A (pt) Derivado de sulfonamida processo para a preparação de um derivado de sulfonamida e seus sais fisiologicamente aceitáveis, composição farmacêutica e uso de um derivado de sulfonamida
ATE243042T1 (de) Biologisch aktive verbindungen aus ganoderma pfeifferi dms 13239
BR9813651A (pt) Compostos antipicornavirais e métodos para o seu uso e preparação
DE60114772D1 (de) Aromatisches guanylhydrazon zur behandlung resistenter viraler infektionen
BR0108792A (pt) Composto de polipeptìdeo, processo para sua preparação, composição farmacêutica contendo o mesmo, seu uso, método, embalagem comercial e artigo de manufatura
BR0012610A (pt) Novo derivado de difenilpiperidina
WO2002072621A3 (en) Cyclohexapeptide having antimicrobial activity
BR0212535A (pt) Compostos e composições como inibidores de catepsina
CN104970050B (zh) 一种蛋白酶-纳米银配合物及其应用
BR0313725A (pt) derivados de lincomicina que possuem atividade antibacteriana
BR0006301A (pt) Macrólidos antibacterianos e pró-cinéticos
BR9913377A (pt) Composto derivado de aminoálcool
BR0116778A (pt) Composto de peptìdeo, composição farmacêutica contendo o mesmo e seu uso
BR9814933A (pt) Composto, composicao farmaceutica e metodo de tratamento de infeccao por hiv.

Legal Events

Date Code Title Description
B25A Requested transfer of rights approved

Owner name: YAMANOUCHI PHARMACEUTICAL CO., LTD. (JP)

Free format text: TRANSFERIDO POR FUSAO DE: FUJISAWA PHARMACEUTICAL CO., LTD.

B25D Requested change of name of applicant approved

Owner name: ASTELLAS PHARMA INC. (JP)

Free format text: ALTERADO DE: YAMANOUCHI PHARMACEUTICAL CO., LTD.

B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 8A , 9A E 10A ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2112 DE 28/06/2011.